10 Autoimmune Diseases That Vary in Prevalence Across Populations

9. Hashimoto's Thyroiditis - Iodine, Genetics, and Geographic Clustering

Photo Credit: AI-Generated

Hashimoto's thyroiditis, the most common cause of hypothyroidism in iodine-sufficient areas, demonstrates significant population-based variation influenced by genetic factors, iodine intake, and environmental conditions. This autoimmune condition affecting the thyroid gland shows particularly high prevalence in populations with adequate or excessive iodine intake, including many developed countries, while being less common in iodine-deficient regions. Japanese populations have historically shown some of the highest rates of Hashimoto's thyroiditis, likely related to their traditionally high iodine intake from seaweed consumption, with prevalence rates reaching 10-15% in some studies of older women. Scandinavian countries also report elevated rates, possibly due to both genetic factors and iodine supplementation programs. The condition shows a strong female predominance across all populations, with women being 5-10 times more likely to be affected, though the exact ratio varies between ethnic groups. Genetic studies have identified population-specific risk alleles, including variants in HLA genes, CTLA-4, and PTPN22, which show different frequencies across ethnic groups. Ashkenazi Jewish populations demonstrate elevated rates compared to other groups in the same geographic areas, suggesting genetic founder effects. Environmental factors play crucial roles, with iodine intake being particularly important – populations transitioning from iodine deficiency to sufficiency often show temporary increases in autoimmune thyroid disease. Selenium deficiency, which is more common in certain geographic regions, may also contribute to population differences in Hashimoto's prevalence and severity. The clinical presentation can vary between populations, with some groups more likely to develop goiter while others may present primarily with hypothyroid symptoms.

10. Psoriasis - Climate, Genetics, and Cultural Factors

Photo Credit: AI-Generated

Psoriasis, a chronic autoimmune skin condition, exhibits remarkable population-based variation with higher prevalence in Northern European populations and lower rates in many Asian, African, and Native American groups, reflecting complex interactions between genetic susceptibility, environmental triggers, and cultural factors. This condition affects approximately 2-3% of the global population but shows dramatic geographic clustering, with Scandinavian countries reporting some of the highest rates, reaching up to 11% in certain regions of Norway. The Faroe Islands hold the distinction of having the world's highest reported psoriasis prevalence, with rates exceeding 2.8% of the population. Conversely, many sub-Saharan African populations, East Asian groups, and indigenous populations of the Americas show significantly lower rates, often below 0.5%. Genetic studies have identified over 60 susceptibility loci for psoriasis, with the HLA-C*06:02 allele being particularly important in European populations but less relevant in many non-European groups. Different populations may have distinct genetic risk profiles, with some variants being protective in certain ethnic groups while being risk factors in others. Environmental factors contribute significantly to population differences, with climate playing a crucial role – UV exposure generally improves psoriasis, which may partly explain the lower prevalence in sunny, tropical regions. However, this relationship is complex, as some sunny regions still show elevated rates. Cultural factors, including clothing practices, dietary habits, and stress levels, also contribute to population differences. The clinical presentation of psoriasis can vary between populations, with some groups more likely to develop certain subtypes or experience different patterns of joint involvement in psoriatic arthritis.

BACK
(5 of 7)
NEXT
BACK
(5 of 7)
NEXT

MORE FROM WorldHealthHelp

    MORE FROM WorldHealthHelp

      MORE FROM WorldHealthHelp